Susquehanna International Group
CALA

Susquehanna International Group’s Calithera Biosciences, Inc CALA Stock Holding History

Susquehanna International Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,875
Closed -$23K – 14518
2022
Q1 		$23K Sell
2,875
-55
-2% -$562 ﹤0.01% 12594
2021
Q4 		$39K Sell
2,930
-8,050
-73% -$202K ﹤0.01% 12675
2021
Q3 		$479K Buy
10,980
+3,870
+54% +$167K ﹤0.01% 9502
2021
Q2 		$297K Sell
7,110
-950
-12% -$41.7K ﹤0.01% 10793
2021
Q1 		$390K Sell
8,060
-35,170
-81% -$2.05M ﹤0.01% 10040
2020
Q4 		$4.25M Buy
+43,230
New +$3.79M ﹤0.01% 3695
2020
Q3 		– Sell
-1,925
Closed -$203K – 11390
2020
Q2 		$203K Sell
1,925
-2,370
-55% -$282K ﹤0.01% 9020
2020
Q1 		$381K Buy
4,295
+2,925
+214% +$348K ﹤0.01% 7510
2019
Q4 		$156K Sell
1,370
-445
-25% -$33.5K ﹤0.01% 8926
2019
Q3 		$112K Sell
1,815
-2,040
-53% -$163K ﹤0.01% 9501
2019
Q2 		$301K Sell
3,855
-7,710
-67% -$875K ﹤0.01% 8313
2019
Q1 		$1.56M Buy
11,565
+11,050
+2,146% +$1.16M ﹤0.01% 4174
2018
Q4 		$41K Sell
515
-305
-37% -$30.1K ﹤0.01% 8547
2018
Q3 		$86K Sell
820
-765
-48% -$72.8K ﹤0.01% 8661
2018
Q2 		$159K Sell
1,585
-1,800
-53% -$204K ﹤0.01% 8812
2018
Q1 		$427K Sell
3,385
-65
-2% -$10.1K ﹤0.01% 6957
2017
Q4 		$576K Buy
3,450
+365
+12% +$93.5K ﹤0.01% 6380
2017
Q3 		$972K Sell
3,085
-70
-2% -$22.1K ﹤0.01% 5329
2017
Q2 		$937K Buy
3,155
+375
+13% +$100K ﹤0.01% 5404
2017
Q1 		$642K Buy
+2,780
New +$480K ﹤0.01% 6026
2016
Q3 		– Sell
-500
Closed -$37K – 9265
2016
Q2 		$37K Buy
+500
New +$50.1K ﹤0.01% 8292
2016
Q1 		– Sell
-1,460
Closed -$224K – 9891
2015
Q4 		$224K Sell
1,460
-210
-13% -$31.5K ﹤0.01% 8236
2015
Q3 		$181K Buy
+1,670
New +$216K ﹤0.01% 8786

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's CALA Position: Q3 2022 in Review

Susquehanna International Group sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 10,177 shares — an estimated $25K sold.

Susquehanna International Group first reported a position in CALA in Q4 2014 and held it in 23 quarters. The position peaked at $2.41M in Q1 2018. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • Susquehanna International Group reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 10,177 Calithera Biosciences, Inc shares in Q3 2022, an estimated $25K.
  • Susquehanna International Group first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 23 quarters.
  • Susquehanna International Group's Calithera Biosciences, Inc position peaked at $2.41M in Q1 2018.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.